The biological response modifiers (BRM) program of the National Cancer Institute.
D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008222:Lymphokines / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013951:Thymus Hormones / Q000627:therapeutic use; D014481:United States
D008222:Lymphokines; D013951:Thymus Hormones; D007372:Interferons